Clinical Data Mulls Spinning Off Genetic Test Business; Files $200M Shelf Registration

The firm is considering selling off its genetic testing and biomarker development business, including its CLIA lab.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories